LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

Biosurfactants – Clean and sustainable

18/09/2024

CASE STUDY

Submission from Evonik

The innovation.

Surface active agents (surfactants) are crucial for our daily lives and health because they allow us to clean our clothes, dishes, hands, bodies, and homes. In response to shifting consumer demand towards sustainable products, this fast-growing $40 billion global market for surfactants is now undergoing a rapid transition towards green surfactants that are fully biodegradable, biobased, minimize CO2 emissions and are not harmful to aquatic or other natural organisms.

Biosurfactants such as rhamnolipids are naturally occurring molecules, which can replace conventional surfactants in many applications, for example, washing dishes, cleaning textiles, and personal care. Evonik has developed a proprietary technology to produce rhamnolipids from sugar using an efficient biotechnological process. First, rhamnolipids are produced from sugar by fermentation with a dedicated and safe microorganism. Then, this sustainable and fully biobased product is purified in a specially tailored downstream process. This technology provides a platform for sustainable biosurfactants with tailor-made properties, exceptional biodegradability, and low ecological toxicity.

Evonik is the first company to manufacture rhamnolipids in commercial quantities, thus meeting the growing demand for safe and sustainable surfactants with superior performance properties. In January 2024, the first product was produced at Evonik’s industrial-scale facility for sustainable biosurfactants in Slovenská Ľupča (Slovakia). The official opening of the plant took place on May 29th, 2024. This is the latest milestone in sustainability-driven biosolutions to respond to the high demand for biobased and biodegradable rhamnolipids for cleaning and personal care.

The benefits.

In contrast to other (partially) bio-based surfactants, this biogenic, carbon-based process does not require petrochemical feedstocks or tropical oils. Rhamnolipids are fully biodegradable and offer a sustainable alternative to conventional surfactants due to biobased raw materials and their low toxicological and ecotoxicological profile. Although they are mild, biosurfactants can solubilize oils and remove odours from the skin. Their exceptional foam-forming properties and mildness make them ideal for use in household cleaners and personal care products such as shampoos and micellar water.

Biosurfactants are also effective in extreme conditions, including at high pH and elevated temperatures. This allows their critical micelle concentration (CMC) to form with a lower amount of added surfactant, demonstrating their superior efficiency compared with chemical surfactants. They also offer superior performance in industrial applications such as coatings, mining, as well as oil recovery.

 

Additional materials:

Mueller, Jakob J., and Hans H. Wenk. "Biosurfactants–Nature’s Solution for Today’s Cleaning Challenges." Chimia 75.9 (2021): 752-752.

Biosurfactants by Evonik - Entering a new era of surfactants

A new dimension in sustainable cleansing - Glycolipids by Evonik

Biosurfactants – Clean and sustainable


Download

Share
Communications Team
Communications Team

Related posts

30/09/2025

Public Consultation Response to the European Commission’s 28th Regime proposal


Read more
14/07/2025

EuropaBio Annual Report 2025


Read more
11/07/2025

Industrial Decarbonisation Accelerator Act – EuropaBio Position


Read more

Important links

  • Public Consultation Response to the European Commission’s 28th Regime proposal
  • EuropaBio Annual Report 2025

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.